Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by 68Ga-DOTATOC PET/CT
Abstract Background Low-grade neuroendocrine tumors (NETs) are characterized by an abundance of somatostatin receptors (SSTR) that can be targeted with somatostatin analogs (SSA). When activated with a single dose of SSA, the receptor-ligand complex is internalized, and the receptor is by default re...
Guardado en:
Autores principales: | Ulrika Jahn, Ezgi Ilan, Irina Velikyan, Katarzyna Fröss-Baron, Mark Lubberink, Anders Sundin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SpringerOpen
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f3e995fbfe0340859a0afc0a75e0b79b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
por: Peter Frøhlich Staanum, et al.
Publicado: (2021) -
68Ga-P15-041, A Novel Bone Imaging Agent for Diagnosis of Bone Metastases
por: Rui Guo, et al.
Publicado: (2021) -
Clinical use of Ortho-SUV transosseous hexapod in treatment of lower limb false joints
por: N. V. Tishkov, et al.
Publicado: (2016) -
Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
por: Philippe Thuillier, et al.
Publicado: (2021) -
Octreotide-Resistant Acromegaly: Challenges and Solutions
por: Corica G, et al.
Publicado: (2020)